Compile Data Set for Download or QSAR
Report error Found 56 Enz. Inhib. hit(s) with all data for entry = 50018406
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195377((4'-{[[1-(3-methyl-butyl)-piperidin-4-yl]-(4-penty...)
Affinity DataIC50: 6nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195408(N-[4'-(benzylcarbamoyl-methyl)-biphenyl-4-ylmethyl...)
Affinity DataIC50: 46nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195416(N-(2-dibutylamino-ethyl)-4-pentyl-N-[4'-(thiomorph...)
Affinity DataIC50: 56nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195373(4'-{[(2-dibutylamino-ethyl)-(4-pentyl-benzoyl)-ami...)
Affinity DataIC50: 72nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195407(N-(2-dibutylamino-ethyl)-N-[4'-(2-morpholin-4-yl-2...)
Affinity DataIC50: 74nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195390(4'-{[(2-dibutylamino-ethyl)-(4-pentyl-benzoyl)-ami...)
Affinity DataIC50: 77nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195380(N-{4'-[(benzyl-methyl-carbamoyl)-methyl]-biphenyl-...)
Affinity DataIC50: 91nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195402(N-(4-(benzo[d][1,3]dioxol-5-yl)benzyl)-N-(2-(dibut...)
Affinity DataIC50: 101nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195372(N-biphenyl-4-ylmethyl-N-(2-dibutylamino-ethyl)-4-p...)
Affinity DataIC50: 143nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195388(N-(4-((N-(2-(dibutylamino)ethyl)-4-pentylbenzamido...)
Affinity DataIC50: 154nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195415(N-(4-(benzo[d][1,3]dioxol-5-yl)benzyl)-4-pentyl-N-...)
Affinity DataIC50: 165nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195389((4'-{[(2-dibutylamino-ethyl)-(4-pentyl-benzoyl)-am...)
Affinity DataIC50: 183nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195423(N-(4-thiomorpholinobenzyl)-N-(2-(dibutylamino)ethy...)
Affinity DataIC50: 188nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195422(N-(4-(benzo[d][1,3]dioxol-5-yl)benzyl)-N-(2-(4-ben...)
Affinity DataIC50: 190nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195384(N-(4-(4-phenylpiperazin-1-yl)benzyl)-N-(2-(dibutyl...)
Affinity DataIC50: 200nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195419(N-(4-((N-(2-(dibutylamino)ethyl)-4-pentylbenzamido...)
Affinity DataIC50: 202nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195412(N-(4-(pyridin-4-yl)benzyl)-N-(2-(dibutylamino)ethy...)
Affinity DataIC50: 212nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195378(N-(4-(phenylamino)benzyl)-N-(2-(dibutylamino)ethyl...)
Affinity DataIC50: 224nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195392(N-(4-(1H-pyrrol-1-yl)benzyl)-N-(2-(dibutylamino)et...)
Affinity DataIC50: 240nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195417(N-(4-((N-(2-(dibutylamino)ethyl)-4-pentylbenzamido...)
Affinity DataIC50: 243nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195393(N-(4-(benzyl(methyl)amino)benzyl)-N-(2-(dibutylami...)
Affinity DataIC50: 289nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195404(N-(4-(benzo[d][1,3]dioxol-5-yl)benzyl)-4-pentyl-N-...)
Affinity DataIC50: 334nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195400(N-(4-(benzo[d][1,3]dioxol-5-yl)benzyl)-N-(2-(benzy...)
Affinity DataIC50: 334nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195425(N-(4-(piperidin-1-yl)benzyl)-N-(2-(dibutylamino)et...)
Affinity DataIC50: 369nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195426(N-(4-(pyridin-3-yl)benzyl)-N-(2-(dibutylamino)ethy...)
Affinity DataIC50: 374nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195374(N-(4-(pyridin-2-yl)benzyl)-N-(2-(dibutylamino)ethy...)
Affinity DataIC50: 380nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195396(N-(4-(benzylamino)benzyl)-N-(2-(dibutylamino)ethyl...)
Affinity DataIC50: 429nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195397(N-((6-(benzo[d][1,3]dioxol-5-yl)pyridin-3-yl)methy...)
Affinity DataIC50: 437nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195386(N-(4-(benzo[d][1,3]dioxol-5-yl)benzyl)-N-(2-((2-(d...)
Affinity DataIC50: 439nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195376((4'-{[(2-dibutylamino-ethyl)-(4-pentyl-benzoyl)-am...)
Affinity DataIC50: 463nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195379(N-(4-((N-(2-(dibutylamino)ethyl)-4-pentylbenzamido...)
Affinity DataIC50: 464nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195398(N-(2-dibutylamino-ethyl)-N-[4'-(2-hydroxy-ethoxy)-...)
Affinity DataIC50: 511nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195406(N-(4-(benzo[d][1,3]dioxol-5-yl)benzyl)-N-(2-(dipro...)
Affinity DataIC50: 531nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195383(N-(4-(pyrimidin-5-yl)benzyl)-N-(2-(dibutylamino)et...)
Affinity DataIC50: 531nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195418(N-(4-(methyl(phenyl)amino)benzyl)-N-(2-(dibutylami...)
Affinity DataIC50: 574nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195409(N-(2-(dibutylamino)ethyl)-4-pentyl-N-((6-(pyridin-...)
Affinity DataIC50: 587nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195381(N-(2-(dibutylamino)ethyl)-4-pentyl-N-((6-phenylpyr...)
Affinity DataIC50: 589nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195427(N-(2-(dibutylamino)ethyl)-4-pentyl-N-((6-(pyridin-...)
Affinity DataIC50: 642nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195413(N-(4-(4-benzylpiperazin-1-yl)benzyl)-N-(2-(dibutyl...)
Affinity DataIC50: 646nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195411(N-(4-(1H-indol-1-yl)benzyl)-N-(2-(dibutylamino)eth...)
Affinity DataIC50: 670nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195375(N-(2-(dibutylamino)ethyl)-4-pentyl-N-((6-(pyridin-...)
Affinity DataIC50: 736nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195421(N-(4-(diethylamino)benzyl)-N-(2-(dibutylamino)ethy...)
Affinity DataIC50: 1.49E+3nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195399(N-(4-(benzo[d][1,3]dioxol-5-yl)benzyl)-N-(2-(diiso...)
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195405(N-(4-(benzo[d][1,3]dioxol-5-yl)benzyl)-N-(2-(dieth...)
Affinity DataIC50: 1.52E+3nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195395(N-(1-benzylpiperidin-4-yl)-4-pentyl-N-(3-phenylpro...)
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195414(N-(4-(pyridin-4-ylamino)benzyl)-N-(2-(dibutylamino...)
Affinity DataIC50: 1.82E+3nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195410(N-((5-(benzo[d][1,3]dioxol-5-yl)pyridin-2-yl)methy...)
Affinity DataIC50: 1.91E+3nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195401(N-(2-(dibutylamino)ethyl)-4-pentyl-N-((6-(pyrimidi...)
Affinity DataIC50: 2.23E+3nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195403(N-(2-(dibutylamino)ethyl)-4-pentyl-N-((5-phenylpyr...)
Affinity DataIC50: 2.35E+3nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasmepsin II(Plasmodium falciparum)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50195391(N-(4-(4-methylpiperazin-1-yl)benzyl)-N-(2-(dibutyl...)
Affinity DataIC50: 2.55E+3nMAssay Description:Inhibition of PM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 56 total ) | Next | Last >>
Jump to: